The company was founded in 2001. It is the first batch of “National High-tech Industrialization Demonstration Project” key high-tech enterprises awarded by the National Development and Reform Commission, and is a listed company on the Science and Technology Innovation Board of the Shanghai Stock Exchange. With the strategic goal of “building a national industrial brand and leading the development of the industry”, the company adheres to the values of “technology creates value and returns to society before science”, and vigorously promotes management innovation, scientific and technological innovation, marketing innovation and service innovation with innovation as the driving force. The company is a biomedical enterprise focusing on R&D, production, sales of veterinary biological products and animal epidemic prevention technology services. The company's main products are non-national compulsory vaccination swine vaccines and poultry vaccines. Corporate honors: Second prize of the National Science and Technology Progress Award, the first prize of the Hubei Science and Technology Progress Award, National Key New Products, Hubei Top 100 Manufacturing Enterprises, Hubei Province's “Specialized, Special and New” Little Giant Enterprises, Top 50 Private Manufacturing Enterprises in Wuhan, Wuhan Agricultural Science and Technology Enterprises, Outstanding Private Enterprises in Wuhan City, and Leading Agricultural Enterprises in Wuhan.